Purchase Order 75N95020P00559
Award Date 9/8/20
Potential Completion Date 12/7/20
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Delivery Order under the "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite Delivery Indefinite Quantity (IDIQ) contract, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Duke University. The contract is for administrative and overall clinical operations support under NIDA's Phase I clinical trials program for developing neurotherapeutics. The fixed-price delivery order has a ceiling value of $409,541.00 and a period of...
- The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...
- The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
- The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Carol Rodeffer (UEI: DYWDJKBV5Z14) on October 30, 2009, with a ceiling value of $40,600. This fee-for-service contract covers the period from October 1, 2009, through September 30, 2010, with an ultimate completion date of October 29, 2010. The contract was performed in Bethesda, Maryland, and no set-aside designation was utilized in the award. As a civilian agency component of the National Institutes of Health,...
- This federal contract award is a delivery order under a larger contract vehicle, with Research Triangle Institute (RTI) International as the prime contractor. The contract is with the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The award, valued at $376,358.00, is for the synthesis and distribution of drugs of abuse and related compounds over a one-year period from June 16, 2024 to June 15, 2025, with a total period of...
- The National Institute on Drug Abuse awarded a definitive cost-no-fee contract to University of North Carolina At Chapel Hill for the Psychoactive Drug Screening Program (PDSP) on August 30, 2023, with a ceiling value of $17.834 million and ultimate completion date of August 29, 2028. The contract performs ongoing screening services for NIMH, supporting fundamental research on psychoactive compounds through broad-based pharmacological and functional assays against hundreds of central nervous...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $415,717 to Technical Resources International, Inc. (TRI), a minority-owned and woman-owned small business based in Bethesda, Maryland, for a Phase I Single Ascending Dose Study under the Pharmacokinetic Analysis Resource Center program. The contract, awarded on September 10, 2024, with an ultimate completion date of March 8, 2027, represents a cost-plus-fixed-fee engagement. This delivery order was issued under...
- The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded a delivery order valued at $1.96 million to Research Triangle Institute (RTI International) for the synthesis and distribution of drugs of abuse and related compounds. This task order (TO8, N01DA-22-8944) runs from June 9, 2025 through June 8, 2026, with an ultimate completion date of June 8, 2027, and utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation. The work will...
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...